Defence Research and Development Canada
14
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 30/100
14.3%
2 terminated/withdrawn out of 14 trials
84.6%
-1.9% vs industry average
50%
7 trials in Phase 3/4
73%
8 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Ketamine Infusion in Neurologic Deficit
Role: collaborator
Remote Ischemic Conditioning as a Treatment for Traumatic Brain Injury
Role: collaborator
Pathophysiological Understanding and Treatment of PTSD: an rTMS Approach
Role: collaborator
RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study
Role: collaborator
Pragmatic, Randomized Optimal Platelet and Plasma Ratios
Role: collaborator
Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery
Role: collaborator
Prehospital Tranexamic Acid Use for Traumatic Brain Injury
Role: collaborator
Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using an Impedance Valve
Role: collaborator
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Role: collaborator
Continuous Chest Compressions vs AHA Standard CPR of 30:2
Role: collaborator
The Toronto Prehospital Hypertonic Resuscitation Head Injury and Multi Organ Dysfunction Trial (TOPHR HIT)
Role: collaborator
Automated Real-time Feedback on CPR Study
Role: collaborator
Hypertonic Resuscitation Following Traumatic Injury
Role: collaborator
Feasibility Trial of Traumatic Brain Injured Patients Randomized in the Prehospital Setting to Either Hypertonic Saline and Dextran Versus Normal Saline
Role: collaborator
All 14 trials loaded